Dr Ronald D Hall, MD - Medicare Dermatology in Pikeville, KY

Dr Ronald D Hall, MD is a medicare enrolled "Dermatology" physician in Pikeville, Kentucky. He went to University Of Kentucky College Of Medicine and graduated in 1974 and has 50 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Modern Dermatology Of Kentucky Llc and his current practice location is 1098 S Mayo Trl, Suite 211, Pikeville, Kentucky. You can reach out to his office (for appointments etc.) via phone at (606) 432-5532.

Dr Ronald D Hall is licensed to practice in Kentucky (license number 19685) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1902857980.

Contact Information

Dr Ronald D Hall, MD
1098 S Mayo Trl, Suite 211,
Pikeville, KY 41501-1546
(606) 432-5532
(606) 432-5564



Physician's Profile

Full NameDr Ronald D Hall
GenderMale
SpecialityDermatology
Experience50 Years
Location1098 S Mayo Trl, Pikeville, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ronald D Hall attended and graduated from University Of Kentucky College Of Medicine in 1974
  NPI Data:
  • NPI Number: 1902857980
  • Provider Enumeration Date: 05/13/2006
  • Last Update Date: 03/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9537052626
  • Enrollment ID: I20040610000195

Medical Identifiers

Medical identifiers for Dr Ronald D Hall such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902857980NPI-NPPES
0758582OtherUMWA
610944002007MedicaidWV
005940303MedicaidVA
000000046151OtherKYANTHEM OF KY
048726OtherVAANTHEM OF VA
64-196850MedicaidKY
610944002007OtherWVMOUNTAIN STATE BCBS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 19685 (Kentucky)Primary
174400000XSpecialist 19685 (Kentucky)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Modern Dermatology Of Kentucky Llc549616630813

News Archive

Virus widely used in gene therapy research yields important clues to genomic instability

Genomic instability, the rearrangement of chromosomes or an abnormal number of chromosomes, is a hallmark of many human cancers.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

In historic vote, House passes sweeping health bill

Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ronald D Hall allows following entities to bill medicare on his behalf.
Entity NameDermatology Associates Of Pikeville, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811285117
PECOS PAC ID: 6709058035
Enrollment ID: O20111011000426

News Archive

Virus widely used in gene therapy research yields important clues to genomic instability

Genomic instability, the rearrangement of chromosomes or an abnormal number of chromosomes, is a hallmark of many human cancers.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

In historic vote, House passes sweeping health bill

Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.

Read more Medical News

› Verified 6 days ago

Entity NameModern Dermatology Of Kentucky Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699382507
PECOS PAC ID: 5496166308
Enrollment ID: O20201125001868

News Archive

Virus widely used in gene therapy research yields important clues to genomic instability

Genomic instability, the rearrangement of chromosomes or an abnormal number of chromosomes, is a hallmark of many human cancers.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

In historic vote, House passes sweeping health bill

Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ronald D Hall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ronald D Hall, MD
Po Box 2500,
Pikeville, KY 41502-2500

Ph: (606) 432-5532
Dr Ronald D Hall, MD
1098 S Mayo Trl, Suite 211,
Pikeville, KY 41501-1546

Ph: (606) 432-5532

News Archive

Virus widely used in gene therapy research yields important clues to genomic instability

Genomic instability, the rearrangement of chromosomes or an abnormal number of chromosomes, is a hallmark of many human cancers.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.

Organ-on-chip consortium receives huge grant to develop a universal standard for pharmaceutical industry

Scientists are pushing ahead building 'organ-on-chips', small chips with human cells, which are useful, for example, for studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.

In historic vote, House passes sweeping health bill

Kaiser Health News senior correspondent Mary Agnes Carey reports that, by a vote of 219-210, the House of Representatives has cleared the Senate-passed health care bill for President Barack Obama's signature. The House will now vote on a separate package of legislative changes to that bill - known as a reconciliation package - to send it to the Senate for debate this week.

Read more News

› Verified 6 days ago


Dermatology Doctors in Pikeville, KY

Harty Elouise Ashby, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 911 Bypass Rd, Pikeville, KY 41501
Phone: 606-218-3500    
Dr. Brookelynn Hensley, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 911 Bypass Rd Bldg C, Pikeville, KY 41501
Phone: 606-430-2210    Fax: 606-432-2404
Dr. Timothy R Lavender, D.O.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 108 N Auxier Ave, Pikeville, KY 41501
Phone: 606-432-9106    Fax: 606-432-0967

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.